- Filed
- May 5, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 26.53M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 23.41M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 19.94M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$6.51M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$4.17M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $25.13M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $31.63M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $14.22M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $18.41M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $20.95M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $9.71M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $11.18M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $13.3M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $11.18M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $13.3M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $25.4M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $31.71M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $25.4M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $31.71M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.26 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.27 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.26 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.27 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $2.15M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.89M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $4.11M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $3.68M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$6.05M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$5.33M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$6.26M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$5.57M |